Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment

類似資料

• Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjects
  著者:: Shin, Kwang-Hee, 等
  出版事項: (2010)
• Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction
  著者:: Kim, Tae-Eun, 等
  出版事項: (2009)
• Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment
  著者:: Venkatakrishnan, Karthik, 等
  出版事項: (2014)
• Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment
  著者:: Venkatakrishnan, Karthik, 等
  出版事項: (2014)
• Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
  著者:: Kim, Bo-Hyung, 等
  出版事項: (2008)